Cargando…
CADM1 is a strong neuroblastoma candidate gene that maps within a 3.72 Mb critical region of loss on 11q23
BACKGROUND: Recurrent loss of part of the long arm of chromosome 11 is a well established hallmark of a subtype of aggressive neuroblastomas. Despite intensive mapping efforts to localize the culprit 11q tumour suppressor gene, this search has been unsuccessful thus far as no sufficiently small crit...
Autores principales: | Michels, Evi, Hoebeeck, Jasmien, De Preter, Katleen, Schramm, Alexander, Brichard, Bénédicte, De Paepe, Anne, Eggert, Angelika, Laureys, Geneviève, Vandesompele, Jo, Speleman, Frank |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2442116/ https://www.ncbi.nlm.nih.gov/pubmed/18559103 http://dx.doi.org/10.1186/1471-2407-8-173 |
Ejemplares similares
-
No evidence for involvement of SDHD in neuroblastoma pathogenesis
por: De Preter, Katleen, et al.
Publicado: (2004) -
The emerging molecular pathogenesis of neuroblastoma: implications for improved risk assessment and targeted therapy
por: Van Roy, Nadine, et al.
Publicado: (2009) -
Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes
por: De Preter, Katleen, et al.
Publicado: (2006) -
Correction: Human fetal neuroblast and neuroblastoma transcriptome analysis confirms neuroblast origin and highlights neuroblastoma candidate genes
por: De Preter, Katleen, et al.
Publicado: (2007) -
methBLAST and methPrimerDB: web-tools for PCR based methylation analysis
por: Pattyn, Filip, et al.
Publicado: (2006)